Permeability properties of the Bufo bufo bladder as affected by isoprenaline and vasopressin.

Archives internationales de physiologie et de biochimie
C Lippe, C Ardizzone

Abstract

Isoprenaline, a beta adrenergic agonist, strongly increases both transepithelial fluxes across the urinary bladder of Bufo bufo; this effect is dose dependent, 10(-6)M being necessary for the maximal action. This effect is less selective than that of vasopressin: the ratio J urea/J thiourea is 3.8 under isoprenaline and 30.4 under vasopressin treatment. Both hormones differently affect the permeability of a mainly liposoluble molecule, i.e. antipyrine: vasopressin increases antipyrine permeability, while isoprenaline decreases it. Moreover diethylpyrocarbonate treatment of the luminal membrane strongly inhibits vasopressin effect on urea permeability leaving unmodified that of isoprenaline. However, the actions of both hormones are not additive. These results allows to assume that the tissue has a feedback mechanism which inhibits other hormonal action while the bladder is stimulated by a particular hormone.

References

Jan 1, 1975·The Journal of Membrane Biology·R J Pietras, E M Wright
Feb 17, 1976·The Journal of Membrane Biology·S D Levine, R E Worthington
Nov 15, 1974·Biochimica Et Biophysica Acta·A W Wood, R W Tomlinson
Nov 1, 1968·The American Journal of Physiology·J S HandlerJ Orloff
Jun 1, 1972·Comparative Biochemistry and Physiology. A, Comparative Physiology·C LippeE Gallucci
Jun 1, 1973·The Journal of Clinical Investigation·S LevineR M Hays
Mar 20, 1958·The Journal of General Physiology·A LEAFL B PAGE

❮ Previous
Next ❯

Citations

Feb 1, 1992·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·C Lippe, C Ardizzone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.